On 10/16/24, Novavax Inc (NASDAQ: NVAX) stock suffered a major decline of -19.4%, closing at $10.15. Moreover, trading volume in this decline was exceptionally high at 499% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -22.2% during the last week.
Current PriceTarget Research Rating
NVAX’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a major Value Eraser.
Novavax is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment